Galacto-oligosaccharides
Also known as: GOS, galactooligosaccharides, galacto-oligosaccharides
Randomized trials and meta-analyses indicate that dietary fibres including GOS increase faecal Bifidobacterium abundance compared with low-fibre or placebo comparators; GOS-containing supplements or formulas have been shown to sustain higher bifidobacteria in infants and to alter maternal and infant stool microbiota and some short-chain fatty acids in trials cited here.
Last reviewed: 2026-10-14 · 4 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Galacto-oligosaccharides (GOS) are non-digestible oligosaccharides used as prebiotics to selectively stimulate beneficial gut bacteria. Human trials and meta-analyses report increases in bifidobacteria abundance and some changes in short-chain fatty acids following GOS-containing interventions.
Mechanism & Function
Mechanism of Action
GOS resist digestion in the upper gastrointestinal tract and are fermented by resident microbes, preferentially stimulating bifidobacteria and lactobacilli and producing short-chain fatty acids that can affect local gut environment and host signalling.
Physiological Role
Selective fermentation substrate for commensal gut bacteria, leading to shifts in bacterial composition and microbial metabolites such as acetate and butyrate.
Primary Pathways
Performance / Health Relevance
Not an ergogenic agent; relevance is to gut microbial composition and downstream markers of gut and potentially immune/metabolic health. Effects are primarily microbial (increased bifidobacteria) and metabolic (changes in some faecal SCFAs).
Evidence Review
Practical Use & Dosage
- Minimum Effective Dose
- Effects on maternal and infant microbiota reported with 14.2 g/day GOS/FOS (maternal trial); meta-analysis includes a variety of fibre doses but specific minimum effective doses for GOS alone are not consistently reported in the provided abstracts.
- Optimal Range
- Not established from provided abstracts.
- Upper / Caution Level
- Not established from provided abstracts.
- Timing
- Daily administration in studies; often mixed into formula or taken as a powder supplement during pregnancy/lactation or added to infant formula.
- Best Format
- Powder mixed into formula or food; included as formula additive for infants.
- Bioavailability
- Non-digestible carbohydrate that reaches the colon intact and is fermented by gut bacteria.
- Absorption Considerations
- Fermentation can produce gas and short-chain fatty acids; individuals may experience transient gastrointestinal symptoms such as bloating or flatulence.
Safety & Interactions
Side Effects
- •Bloating
- •Flatulence
- •Diarrhoea or loose stools at higher intakes
Contraindications
- Known intestinal obstruction or severe gastrointestinal motility disorders (consult clinician)
Drug Interactions
- •No specific drug interactions reported in the provided abstracts.
Who Should Avoid
- •Individuals with severe gastrointestinal disease should consult a clinician before use
Monitoring
Monitor gastrointestinal tolerance (bloating, gas, stool frequency/consistency). Seek medical advice if severe symptoms occur.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Galacto-oligosaccharides typically used or indicated?
Galacto-oligosaccharides is most commonly used for: Prebiotic to support gut microbiota, Included in infant formula to promote bifidobacteria, Maternal supplementation during pregnancy/lactation to influence infant microbiome. Selective fermentation substrate for commensal gut bacteria, leading to shifts in bacterial composition and microbial metabolites such as acetate and butyrate.
How does Galacto-oligosaccharides work?
GOS resist digestion in the upper gastrointestinal tract and are fermented by resident microbes, preferentially stimulating bifidobacteria and lactobacilli and producing short-chain fatty acids that can affect local gut environment and host signalling.
What is the recommended dose of Galacto-oligosaccharides?
The optimal range is Not established from provided abstracts.. with a minimum effective dose of Effects on maternal and infant microbiota reported with 14.2 g/day GOS/FOS (maternal trial); meta-analysis includes a variety of fibre doses but specific minimum effective doses for GOS alone are not consistently reported in the provided abstracts.. Best taken: Daily administration in studies; often mixed into formula or taken as a powder supplement during pregnancy/lactation or added to infant formula.. Upper / caution level: Not established from provided abstracts..
What are the side effects of Galacto-oligosaccharides?
Reported side effects include: Bloating; Flatulence; and Diarrhoea or loose stools at higher intakes. Monitoring: Monitor gastrointestinal tolerance (bloating, gas, stool frequency/consistency). Seek medical advice if severe symptoms occur.
Does Galacto-oligosaccharides interact with medications?
Known or theoretical interactions: No specific drug interactions reported in the provided abstracts.. Always check with a clinician before combining with prescription medication.
Who should avoid Galacto-oligosaccharides?
Galacto-oligosaccharides is generally not recommended for: Individuals with severe gastrointestinal disease should consult a clinician before use; and Known intestinal obstruction or severe gastrointestinal motility disorders (consult clinician).
How strong is the evidence for Galacto-oligosaccharides?
Evidence level: Moderate (overall score 73/100), based on 4 indexed studies on SuppIndex.
Research & References (4)
Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis.
Systematic review and meta-analysis of 64 RCTs in healthy adults comparing dietary fibre interventions with placebo/low-fibre comparators, including subgroup analysis by fibre type.
The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.
Systematic review of probiotics, prebiotics, and synbiotics taken during pregnancy/lactation and effects on gut microbiota of cesarean-born infants; included interventions combining probiotics with prebiotics such as GOS.
Diurnal rhythmicity of infant fecal microbiota and metabolites: A randomized controlled interventional trial with infant formula.
Randomized controlled trial of infant formula containing GOS versus formula with bifidobacteria or placebo in 210 infants, with longitudinal stool sampling over the first year.
Maternal prebiotic supplementation during pregnancy and lactation modifies the microbiome and short chain fatty acid profile of both mother and infant.
Double-blind RCT where pregnant/lactating women received 14.2 g/day of a prebiotic powder (GOS:FOS 9:1) versus placebo, with maternal and infant stool sampled to assess microbiota and faecal SCFA.
Related Ingredients
Other top-rated ingredients in General Health Ingredients.
Piperine
82/100A piperidine alkaloid (C₁₇H₁₉NO₃) that inhibits cytochrome P450 enzymes (CYP3A4, CYP1A2, CYP2E1), P-glycoprotein efflux transporters, and UDP-glucuronosyltransferases while enhancing intestinal permeability, digestive enzyme secretion, and splanchnic blood flow — collectively producing dramatic improvements in nutrient bioavailability.
CoQ10
78/100Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles electrons in the mitochondrial respiratory chain and acts as a membrane antioxidant.
Beta-Glucan (Oat)
77/100Multiple randomized trials and meta-analyses report that ≥3 g/day oat beta-glucan lowers LDL and total cholesterol modestly. Acute feeding trials pooled in meta-analysis show dose- and molecular-weight–dependent reductions in postprandial glucose and insulin responses.
Research Overview
Moderate EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/galacto-oligosaccharides
SuppIndex. (2026). Galacto-oligosaccharides: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/galacto-oligosaccharides
Based on 4 indexed studies · Evidence level: Moderate.
Goal Ratings
Stack Compatibility
Commonly combined with probiotic strains (synbiotics) in trials; co-administration with probiotics has been used to target Bifidobacterium colonisation.
